Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, Guillén D, Hutchinson M, Sherman ME, Eklund C, Schussler J, Buckland J, Morera LA, Cárdenas F, Barrantes M, Pérez E, Cox TJ, Burk RD, Herrero R. Bratti MC, et al. Among authors: hutchinson m. Rev Panam Salud Publica. 2004 Feb;15(2):75-89. doi: 10.1590/s1020-49892004000200002. Rev Panam Salud Publica. 2004. PMID: 15030652
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.
Herrero R, Hildesheim A, Rodríguez AC, Wacholder S, Bratti C, Solomon D, González P, Porras C, Jiménez S, Guillen D, Morales J, Alfaro M, Cyr J, Morrisey K, Estrada Y, Cortés B, Morera LA, Freer E, Schussler J, Schiller J, Lowy D, Schiffman M; Costa Rica Vaccine Trial (CVT) Group. Herrero R, et al. Vaccine. 2008 Sep 2;26(37):4795-808. doi: 10.1016/j.vaccine.2008.07.002. Epub 2008 Jul 18. Vaccine. 2008. PMID: 18640170 Free PMC article. Clinical Trial.
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD. Rodríguez AC, et al. Among authors: hutchinson m. J Natl Cancer Inst. 2010 Mar 3;102(5):315-24. doi: 10.1093/jnci/djq001. Epub 2010 Feb 15. J Natl Cancer Inst. 2010. PMID: 20157096 Free PMC article.
Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Cheung L, Wacholder S, Burk RD. Rodríguez AC, et al. Among authors: hutchinson m. Int J Cancer. 2012 Oct 15;131(8):1874-81. doi: 10.1002/ijc.27418. Epub 2012 Feb 28. Int J Cancer. 2012. PMID: 22213126 Free PMC article.
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica.
Herrero R, Wacholder S, Rodríguez AC, Solomon D, González P, Kreimer AR, Porras C, Schussler J, Jiménez S, Sherman ME, Quint W, Schiller JT, Lowy DR, Schiffman M, Hildesheim A; Costa Rica Vaccine Trial Group. Herrero R, et al. Cancer Discov. 2011 Oct;1(5):408-19. doi: 10.1158/2159-8290.CD-11-0131. Epub 2011 Sep 9. Cancer Discov. 2011. PMID: 22586631 Free PMC article. Clinical Trial.
Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.
Lang Kuhs KA, Gonzalez P, Rodriguez AC, van Doorn LJ, Schiffman M, Struijk L, Chen S, Quint W, Lowy DR, Porras C, DelVecchio C, Jimenez S, Safaeian M, Schiller JT, Wacholder S, Herrero R, Hildesheim A, Kreimer AR; Costa Rica Vaccine Trial Group. Lang Kuhs KA, et al. J Infect Dis. 2014 Dec 15;210(12):1890-9. doi: 10.1093/infdis/jiu357. Epub 2014 Jun 23. J Infect Dis. 2014. PMID: 24958910 Free PMC article. Clinical Trial.
A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer.
Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, Burk RD, Hutchinson M, Alfaro M, Greenberg MD, Morales J, Rodriguez AC, Schussler J, Eklund C, Marshall G, Schiffman M. Ferreccio C, et al. Among authors: hutchinson m. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):815-23. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504189
1,476 results